Yung-Chang Lin

33PUBLICATIONS

81CO-AUTHORS

PharmacogenomicsNutrigenomics and personalised nutritionExercise physiologyHuman rights and justice issues (excl. law)Innate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|May 21, 2026

Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B.

|Mar 11, 2026

Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis.

Yuan-Hung Kuo, Wei Teng, Yen-Hao Chen

|Jan 10, 2026

Associations Between the Severity of Sarcopenia and Health-Related Quality of Life in Older Adults.

Wei-Syun Hung, Ying-Jen Chen, Tz-Shiu Tsai

|Nov 24, 2025

Response to Letter to the Editor 'Key Considerations to Broaden the Validity of HCV-Related LC/CLD Mortality Research in Taiwan'.

Cheng-Yeh Yang, Chun-Yen Lin, Rong-Nan Chien

|Oct 16, 2025

Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab.

Tai-Chi Wu, Po-Ting Lin, Wei Teng

|Oct 26, 2024

Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.

Yu-Chun Hsu, Po-Ting Lin, Wei Teng

Pageof 6

Frequent Collaborators

Wen-Juei Jeng

Jia-Horng Kao

Ming-Lung Yu

Rong-Nan Chien

Yung-Chang Lin

Chen-Chun Lin

Chen-Hua Liu

Cheng-Yuan Peng

Yi-Hsiang Huang

Tsung-Hui Hu

Frequent Collaborators

Wen-Juei Jeng

Jia-Horng Kao

Ming-Lung Yu

Rong-Nan Chien